Genmab says new arbitration builds on a straightforward question
”I think this is a much simpler case than the first arbitration,” says Genmab CEO Jan van de Winkel on the new legal suit brought against Janssen, which stems from a fight Genmab has already lost once.
by marketwire, translated by daniel pedersen
Having lost an arbitration case against its partner Janssen in April, Genmab chose to bring a new suit against the company based on the earlier ruling.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
New arbitration full of upsides for Genmab, says analyst
For subscribers
